US2021032667A1PendingUtilityA1
Recombinant microorganism for improved production of alanine
Est. expiryJun 12, 2035(~8.9 yrs left)· nominal 20-yr term from priority
C12N 9/0016C12Y 102/01011C12Y 104/01004C12N 9/0008C12P 13/06
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a recombinant nucleic acid molecule, a recombinant microorganism, to a method for producing alanine and to the use of the recombinant nucleic acid molecule or the recombinant microorganism for the fermentative production of alanine.
Claims
exact text as granted — not AI-modified1 . A recombinant microorganism comprising a reduced, repressed or deleted activity and/or expression of an asd gene or a gdhA gene.
2 . The recombinant microorganism of claim 1 further comprising at least one of the features selected from the group of
(a) an introduced, increased or enhanced activity and/or expression of an alaD gene encoding an alanine dehydrogenase,
(b) a reduced, repressed or deleted activity and/or expression of a pflB gene encoding a pyruvate formate lyase I,
(c) a reduced, repressed or deleted activity and/or expression of an adhE gene encoding a bifunctional acetaldehyde-CoA dehydrogenase/iron-dependent alcohol dehydrogenase/pyruvate-formate lyase deactivase,
(d) a reduced, repressed or deleted activity and/or expression of a ldhA gene encoding a NAO-dependent fermentative D-lactate dehydrogenase,
(e) a reduced, repressed or deleted activity and/or expression of a pta gene encoding a phosphate acetyltransferase and/or a reduced, repressed or deleted activity and/or expression of an ackA gene encoding an acetate kinase A and propionate kinase 2,
(f) a reduced, repressed or deleted activity and/or expression of a frdA gene encoding a fumarate reductase, and/or
(g) a reduced, repressed or deleted activity and/or expression of a dadX gene encoding an alanine racemase,
wherein the reduction, repression, deletion, introduction, increase or enhancement of the activity and/or expression of a gene is determined compared to a respective reference microorganism.
3 - 8 . (canceled)
9 . The recombinant microorganism of claim 1 , further comprising at least one feature selected from the group of:
(a) a reduced, repressed or deleted activity and/or expression of a brnQ gene encoding a brnQ protein having a branched chain amino acid transporter activity, (b) a reduced, repressed or deleted activity and/or expression of a gcvB gene encoding a non-protein encoding RNA, (c) an increased and/or enhanced activity and/or expression of a zipA gene encoding cell division protein involved in Z ring assembly, (d) an increased and/or enhanced activity and/or expression of a lpd gene encoding a lipoamide dehydrogenase, a changed activity of a lpxD gene encoding encoding an UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase protein, an increased and/or enhanced activity and/or expression of a gcvA gene encoding a DNA-binding protein, and/or an increased and/or enhanced activity and/or expression of a ygaW gene encoding an alanine transporter.
10 - 15 . (canceled)
16 . The recombinant microorganism of claim 1 , wherein the asd gene or the gdhA gene is selected from the group of
(i) a nucleic acid molecule comprising a sequence of SEQ ID NO: 25 or SEQ ID NO: 37, or (ii) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 25 or SEQ ID NO: 37, or (iii) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 25 or SEQ ID NO: 37 under stringent conditions, or (iv) a nucleic acid molecule encoding the polypeptide of SEQ ID NO: 26 or SEQ ID NO: 38, or (v) a nucleic acid molecule encoding a polypeptide having at least 60% homology to the polypeptide of SEQ ID NO: 26 or SEQ ID NO: 38.
17 . The recombinant microorganism of claim 2 , wherein the alaD gene is selected from the group consisting of
(AA) a nucleic acid molecule comprising a sequence of SEQ ID NO: 1, or (BB) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 1, or (CC) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 1 under stringent conditions, or (DD) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 2, or (EE) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 2.
18 . The recombinant microorganism of claim 2 , wherein the pflB gene is selected from the group consisting of
(A) a nucleic acid molecule comprising a sequence of SEQ ID NO: 5, or (B) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 5, or (C) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 5 under stringent conditions, or (D) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 6, or (E) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 6.
19 . The recombinant microorganism of claim 2 , wherein the adhE gene is selected from the group consisting of
(F) a nucleic acid molecule comprising a sequence of SEQ ID NO: 7, or (G) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 7, or (H) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 7 under stringent conditions, or (I) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 8, or (J) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 8.
20 . The recombinant microorganism of claim 2 , wherein the ldhA gene is selected from the group consisting of
(K) a nucleic acid molecule comprising a sequence of SEQ ID NO: 9, or (L) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 9, or (M) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 9 under stringent conditions, or (N) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 10, or (O) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 10.
21 . The recombinant microorganism of claim 2 , wherein the pta gene is selected from the group consisting of
(P1) a nucleic acid molecule comprising a sequence of SEQ ID NO: 11, or (Q1) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 11, or (R1) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 11 under stringent conditions, or (S1) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 12, or (T1) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 12 and wherein the ackA gene is selected from the group consisting of (P2) a nucleic acid molecule comprising a sequence of SEQ ID NO: 32, or (Q2) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 32, or (R2) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 32 under stringent conditions, or (S2) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 33, or (T2) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 33.
22 . The recombinant microorganism of claim 2 , wherein the frdA gene is selected from the group consisting of
(U) a nucleic acid molecule comprising a sequence of SEQ ID NO: 13, or (V) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 13, or (W) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 13 under stringent conditions, or (X) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 14, or (Y) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 14.
23 . The recombinant microorganism of claim 2 , wherein the dadX gene is selected from the group consisting of
(Z) a nucleic acid molecule comprising a sequence of SEQ ID NO: 15, or (FF) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 15, or (GG) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 15 under stringent conditions, or (HH) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 16, or (II) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 16.
24 . The recombinant microorganism of claim 9 , wherein the ygaW gene is selected from the group consisting of
(JJ) a nucleic acid molecule comprising a sequence of SEQ ID NO: 17, or (KK) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 17, or (LL) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 17 under stringent conditions, or (MM) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 18, or (NN) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 18.
25 . The recombinant microorganism of claim 9 , wherein the zipA gene is selected from the group consisting of
(OO) a nucleic acid molecule comprising a sequence of SEQ ID NO: 19, or (PP) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 19, or (QQ) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 19 under stringent conditions, or (RR) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 20, or (SS) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 20.
26 . The recombinant microorganism of claim 9 , wherein the lpd gene is selected from the group consisting of
(TT) a nucleic acid molecule comprising a sequence of SEQ ID NO: 21, or (UU) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 21, or (VV) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 21 under stringent conditions, or (WW) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 22, or (XX) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 22.
27 . The recombinant microorganism of claim 9 , wherein the brnQ gene is selected from the group consisting of
(YY) a nucleic acid molecule comprising a sequence of SEQ ID NO: 23, or (ZZ) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 23, or (AAA) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 23 under stringent conditions, or (BBB) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 24, or (CCC) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 24.
28 . The recombinant microorganism of claim 9 , wherein the lpxD gene is selected from the group consisting of
(DDD) a nucleic acid molecule comprising a sequence of SEQ ID NO: 27, or (EEE) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 28.
29 . The recombinant microorganism of claim 9 , wherein the gcvA gene is selected from the group consisting of
(FFF) a nucleic acid molecule comprising a sequence of SEQ ID NO: 29, or (GGG) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 29, or (HHH) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 29 under stringent conditions, or (III) a nucleic acid molecule encoding a polypeptide of SEQ ID NO: 30, or (JJJ) a nucleic acid molecule encoding a polypeptide having at least 60% homology to a polypeptide of SEQ ID NO: 30.
30 . The recombinant microorganism of claim 9 , wherein the gcvB gene is selected from the group consisting of
(KKK) a nucleic acid molecule comprising a sequence of SEQ ID NO: 31, or (LLL) a nucleic acid molecule having at least 80% identity to a nucleic acid molecule of SEQ ID NO: 31, or (MMM) a nucleic acid molecule hybridizing to the complement of a nucleic acid molecule having SEQ ID NO: 31 under stringent conditions.
31 . The recombinant microorganism of claim 1 , wherein the microorganism is selected from a genus of the group consisting of Corynebacterium, Bacillus, Erwinia, Escherichia, Pantoea, Streptomyces, Zymomonas, Rhodococcus, Saccharomyces, Candida or Pichia.
32 - 36 . (canceled)
37 . A method of producing alanine comprising culturing one or more recombinant microorganism according to claim 1 under conditions that allow for the production of alanine
38 - 43 . (canceled)
44 . The method of claim 37 , comprising
I) growing the one or more microorganism in a fermenter to obtain a fermentation broth, and II) recovering alanine from the fermentation broth.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.